A Comparison of the Anxiolytic Properties of Tofisopam and Diazepam: A Double-Blind, Randomized, Crossover, Placebo-Controlled Pilot Study
New clinical reports have recently been published on tofisopam-an anxiolytic drug currently registered as a benzodiazepine-after a long break in this research area. Neurobiological studies concerning its properties, which differ from those of benzodiazepines, are underway. The analyses presented in...
Saved in:
Main Author: | Andrzej Kokoszka (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analgesic efficacy of diazepam and placebo in patients with temporomandibular disorders: A double blind randomized clinical trial
by: G V Pramod, et al.
Published: (2011) -
BounceBack™ capsules for reduction of DOMS after eccentric exercise: a randomized, double-blind, placebo-controlled, crossover pilot study
by: Singh Betsy B, et al.
Published: (2009) -
Does radiofrequency radiation impact sleep? A double-blind, randomised, placebo-controlled, crossover pilot study
by: Nicole Bijlsma, et al.
Published: (2024) -
Effects of previous carbohydrate supplementation on muscular fatigue: double-blind, randomized, placebo-controlled crossover study
by: Rafael A. Battazza, et al. -
URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL
by: S. von Haehling, et al.
Published: (2015)